E. A. Meza Soto, “The Role of GLP-1 Receptor Agonists (Ozempic and Mounjaro) as Secondary Therapy in Chronic Kidney Disease”, Rev. Cienc. Multidiscip. SAGA, vol. 2, no. 3, pp. 973–991, Sep. 2025, doi: 10.63415/saga.v2i3.257.